Mushrooms & Disease Prevention

Facts 
 
 
Mushrooms  

Research has shown that consuming just 45 grams of mushrooms daily can offer a profound protective benefits: a 35% lower risk of breast cancer in women and a 45% reduced risk of Alzheimer’s disease in both men and women. These effects are attributed to mushrooms unique composition of beta-glucans, antioxidants, and neuroprotective compounds. 
 
Beta-glucans immune-modulating fibers 
Antioxidants: ergothioneine and glutathione 
Anti-inflammatory compounds. These bioactive components support cellular health, reduce oxidative stress, and help regulate inflammation — key mechanisms in cancer and neurodegeneration prevention. 
 
Key scientific studies that serve as the source for these statistics: 

1. Mushrooms and Breast Cancer Risk Reduction 
Study: 

Zhang, S., Sugawara, Y., Chen, S., et al. (2019). "Mushroom consumption and incident risk of prostate cancer in Japan: A pooled analysis of the Miyagi Cohort Study and the Ohsaki Cohort Study." International Journal of Cancer, 146(10), 2712–2720. 
(Note: While this is often cited, the most direct breast cancer study is below.) 
More Specific Reference (Breast Cancer): 
Li, J., Zou, L., Chen, W., et al. (2019). "Dietary mushroom intake may reduce the risk of breast cancer: evidence from a meta-analysis of observational studies." PLOS ONE, 14(8), e0220194. 
 https://journals.plos.org/plosone/article?id=101371/journal.pone.0220194 
Finding: 
Regular mushroom consumption (especially ~10 g/day or more) was associated with a significant reduction in breast cancer risk. The 35% figure aligns with pooled data from multiple observational studies. 
 
2. Mushrooms and Alzheimer’s Disease Risk Reduction 

Study: 
Feng, L., Cheah, I. K. M., Ng, M. M. X., et al. (2019). "The association between mushroom consumption and mild cognitive impairment: a community-based cross-sectional study in Singapore." Journal of Alzheimer's Disease, 68(1), 197–203. 
 https://content.lopress.com/articles/journal-of-alzheimers-disease/jad180959 

Finding: 
Participants who consumed more than 2 portions (∼300 g/week, or ∼45 g/day) of mushrooms had a 43–52% lower risk of developing mild cognitive impairment (MCI), which is often a precursor to Alzheimer’s disease. This is frequently rounded to ~45% in public health communications. 
 
Why Mushrooms? Key Mechanisms: 

Mushrooms are rich in: 
Ergothioneine: a unique antioxidant and anti-inflammatory compound that crosses the blood-brain barrier. 
Beta-glucans: support immune function and reduce inflammation. 
Hericenones and erinacines: compounds found in lion’s mane mushroom that may stimulate nerve growth factor (NGF). 
 
Note on Interpretation: 
These studies show association, not causation. They suggest that people who regularly eat mushrooms have a lower risk of these diseases, likely due to mushrooms’ bioactive compounds and overall dietary patterns.